Azithromycin: the first of the tissue-selective azalides

作者: I.M. Hoepelman , M.M.E. Schneider

DOI: 10.1016/0924-8579(95)00009-W

关键词:

摘要: The azalide azithromycin, which is derived from erythromycin, contains a methyl-substituted nitrogen in the lactone ring. This 15-membered expanded ring results improved acid stability and oral bioavailability compared with erythromycin. Azithromycin possesses broad spectrum of activity against Gram-positive Gram-negative bacteria, including enhanced macrolides Haemophilus influenzae Moraxella catarrhalis. In vitro azithromycin intracellular clinically atypical pathogens also good. has distinct pharmacokinetic profile other antimicrobial agents, most prominent feature its high tissue selectivity. Concentrations respiratory tract, gynaecological prostate remain above minimum inhibitory concentrations for several days, thus making it possible to use short-course, once-daily dosing regimen. Another that rapidly penetrates phagocytic cells, release antibiotics at local sites infection. Comparative clinical trials have shown given once daily 3 or 5 days comparable comparator drugs 7 10 treatment otitis media, sinusitis, pharyngitis, acute bronchitis, infectious exacerbations chronic community-acquired pneumonia skin soft infections adults. been be effective tract children. addition, some sexually-transmitted diseases are effectively treated by single 1-g dose azithromycin; microbiological responses were those recorded using doxycycline twice days. short-duration, regimen well tolerated adults children, there no evidence interaction between theophylline, terfenadine, cimetidine.

参考文章(148)
Christian De Duve, Thierry De Barsy, Brian Poole, Andre´ Trouet, Paul Tulkens, Fran¸ois Van Hoof, Commentary. Lysosomotropic agents. Biochemical Pharmacology. ,vol. 23, pp. 2495- 2531 ,(1974) , 10.1016/0006-2952(74)90174-9
C Cioce, G Pestalozza, M Facchini, Azithromycin in upper respiratory tract infections: a clinical trial in children with otitis media. Scandinavian Journal of Infectious Diseases. ,vol. 83, pp. 22- 25 ,(1992)
G. A. Dette, Vergleich der Gewebegängigkeit von Erythromycin Infection. ,vol. 7, pp. 129- 145 ,(1979) , 10.1007/BF01641314
C. A. McNulty, J. C. Dent, Susceptibility of clinical isolates of Campylobacter pylori to twenty-one antimicrobial agents European Journal of Clinical Microbiology & Infectious Diseases. ,vol. 7, pp. 566- 569 ,(1988) , 10.1007/BF01962617
J. E. Hoppe, A. Eichhorn, Activity of new macrolides against Bordetella pertussis and Bordetella parapertussis. European Journal of Clinical Microbiology & Infectious Diseases. ,vol. 8, pp. 653- 654 ,(1989) , 10.1007/BF01968151
K M Kerlikowske, M H Katz, Mycobacterium avium complex and Mycobacterium tuberculosis in patients infected with the human immunodeficiency virus. Western Journal of Medicine. ,vol. 157, pp. 144- 148 ,(1992)
D Pessayre, P Letteron, V Descatoire, D Larrey, J Loeper, G Labbe, M Tinel, Effects of clarithromycin on cytochrome P-450. Comparison with other macrolides. Journal of Pharmacology and Experimental Therapeutics. ,vol. 250, pp. 746- 751 ,(1989)
K. H. Chan, J. D. Swarts, W. J. Doyle, K. Tanpowpong, D. R. Kardatzke, Efficacy of a new macrolide (azithromycin). For acute otitis media in the chinchilla model. Archives of Otolaryngology-head & Neck Surgery. ,vol. 114, pp. 1266- 1269 ,(1988) , 10.1001/ARCHOTOL.1988.01860230060024
D. L. Morris, A. Souza, J. A. Jones, W. E. Morgan, High and prolonged pulmonary tissue concentrations of azithromycin following a single oral dose. European Journal of Clinical Microbiology & Infectious Diseases. ,vol. 10, pp. 859- 861 ,(1991) , 10.1007/BF01975842